Olema Pharmaceuticals (OLMA) Change in Cash (2020 - 2026)

Olema Pharmaceuticals (OLMA) has reported Change in Cash for 7 consecutive years, with $4.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash rose 104.78% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $1.9 million (down 88.73% YoY), while the FY2025 annual figure was -$91.2 million, down 228.53% from the prior year.
• Change in Cash fell to $4.2 million in Q1 2026 per OLMA's latest filing, from $13.0 million in the prior quarter.
• Across five years, Change in Cash topped out at $103.6 million in Q4 2024 and bottomed at -$88.8 million in Q1 2025.
• Historically, Change in Cash has averaged $2.3 million across 5 years, with a median of $2.3 million in 2022.
• On a YoY basis, Change in Cash climbed as much as 3519.36% in 2023 and fell as far as 1475.37% in 2023.
• Olema Pharmaceuticals' Change in Cash stood at -$3.1 million in 2022, then plunged by 1475.37% to -$48.9 million in 2023, then jumped by 311.98% to $103.6 million in 2024, then slumped by 87.41% to $13.0 million in 2025, then slumped by 67.44% to $4.2 million in 2026.
• Business Quant data shows OLMA's Change in Cash at $4.2 million in Q1 2026, $13.0 million in Q4 2025, and -$17.2 million in Q3 2025.